Negative Symptoms in Schizophrenia: Exploring Glutamatergic Modulation Using a Computer-Based Quantitative Systems Pharmacology Approach
Although many antipsychotics can reasonably control positive symptoms in schizophrenia, patients' return to society is often hindered by negative symptoms and cognitive deficits. As an alternative to animal rodent models that are often not very predictive for the clinical situation, we develope...
Saved in:
Main Authors: | Hugo eGeerts (Author), Athan eSpiros (Author), Patrick eRoberts (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2014-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessing the synergy between cholinomimetics and memantine as augmentation therapy in Cognitive Impairment in Schizophrenia. A virtual human patient trial using Quantitative Systems Pharmacology
by: Hugo eGeerts, et al.
Published: (2015) -
A HUMANIZED CLINICALLY CALIBRATED QUANTITATIVE SYSTEMS PHARMACOLOGY MODEL FOR HYPOKINETIC MOTOR SYMPTOMS IN PARKINSON'S DISEASE
by: Hugo eGeerts, et al.
Published: (2016) -
A STRATEGY FOR DEVELOPING NEW TREATMENT PARADIGMS FOR NEUROPSYCHIATRIC AND NEUROCOGNITIVE SYMPTOMS IN ALZHEIMER'S DISEASE
by: Hugo eGeerts, et al.
Published: (2013) -
A quantitative way to estimate clinical off-target effects for human membrane brain targets in CNS research and development
by: Geerts H, et al.
Published: (2012) -
Improving pediatric cancer care disparities across the United States-Mexico border: Lessons learned from a transcultural partnership between San Diego and Tijuana
by: Paula eAristizabal, et al.
Published: (2015)